Literature DB >> 9745420

Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers.

S Laureti1, P Aubourg, F Calcinaro, F Rocchiccioli, G Casucci, G Angeletti, P Brunetti, A Lernmark, F Santeusanio, A Falorni.   

Abstract

Approximately 70-80% of cases of primary adrenal insufficiency are classified as idiopathic. An effective protocol for the etiological diagnosis of primary adrenal insufficiency is needed to ensure correct patient management. With the aim of developing an algorithm for the etiological diagnosis of primary adrenal insufficiency, we studied 56 Italian patients with nonsurgical primary adrenal insufficiency and 24 French patients with X-linked adrenoleukodystrophy (ALD) for serum levels of adrenal cortex, steroid-21-hydroxylase (21OHAb), islet cell (ICA), glutamate decarboxylase (GAD65Ab), IA2/ICA512 (ICA512Ab), thyroid peroxidase (TPOAb) autoantibodies, and plasmatic concentrations of very long chain fatty acids (VLCFA). High levels of 21OH and adrenal cortex antibodies were found in 35/42 (83%) and 17/42 (40%) Italian patients with idiopathic adrenal insufficiency, respectively. Levels of adrenal autoantibodies correlated inversely with disease duration (P < 0.0001). Elevated VLCFA were found in 4/42 (10%) idiopathic patients. A total of 34/35 (97%) idiopathic patients with a disease duration of less than 20 yr was positive for either 21OHSAb or elevated levels of VLCFA. None of 14 patients with posttuberculosis adrenal insufficiency had elevated levels of either adrenal antibodies or VLCFA. ICA, GAD65Ab, ICA512Ab, and TPOAb were found in 6/56 (11%), 8/56 (14%), 4/56 (7%), and 23/56 (41%) patients, respectively. None of 24 French ALD patients with adrenal insufficiency was positive for organ-specific autoantibodies. The measuring of 21OH antibodies and plasma VLCFA levels enabled a correct diagnosis of autoimmune (89%) and ALD (8%) in 97% of patients with idiopathic primary adrenal insufficiency of less than 20 yr of duration. The results of our study have important therapeutic and prognostic implications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745420     DOI: 10.1210/jcem.83.9.5103

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.

Authors:  Peter R Baker; Priyaanka Nanduri; Peter A Gottlieb; Liping Yu; Georgeanna J Klingensmith; George S Eisenbarth; Jennifer M Barker
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

Review 2.  The Changing Face of Adrenoleukodystrophy.

Authors:  Jia Zhu; Florian Eichler; Alessandra Biffi; Christine N Duncan; David A Williams; Joseph A Majzoub
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

3.  Screening for associated autoimmune disorders in Polish patients with Addison's disease.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Jarosław Walkowiak; Magdalena Zurawek; Jerzy Sowiński
Journal:  Endocrine       Date:  2010-03-16       Impact factor: 3.633

Review 4.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

5.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

6.  Adrenomyeloneuropathy in patients with 'Addison's disease': genetic case analysis.

Authors:  Sagarika Mukherjee; Elizabeth Newby; John N Harvey
Journal:  J R Soc Med       Date:  2006-05       Impact factor: 18.000

7.  Addison's disease associated with hypokalemia: a case report.

Authors:  M Abdalla; J A Dave; I L Ross
Journal:  J Med Case Rep       Date:  2021-03-25

Review 8.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

9.  Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.

Authors:  Marta Fichna; Anita Rogowicz-Frontczak; Magdalena Żurawek; Piotr Fichna; Maria Gryczyńska; Dorota Zozulińska-Ziółkiewicz; Marek Ruchała
Journal:  Endocrine       Date:  2016-03-14       Impact factor: 3.633

10.  Tiered healthcare in South Africa exposes deficiencies in management and more patients with infectious etiology of primary adrenal insufficiency.

Authors:  Thabiso Rafaki Petrus Mofokeng; Kwazi Celani Zwakele Ndlovu; Salem A Beshyah; Ian L Ross
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.